Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS' EQUITY (Tables)

v2.4.0.8
STOCKHOLDERS' EQUITY (Tables)
9 Months Ended
Mar. 31, 2014
Stockholders' Equity Note [Abstract]  
Warrant Activity and Related Balances Outstanding
Warrant activity during the nine months ended March 31, 2014, and related balances outstanding as of such dates are reflected below:
 
 
 
Number
 
Weighted
Average
Exercise
Price Per
Share
 
Remaining
Contract
Term (#
years)
 
Shares purchasable under outstanding warrants at June 30, 2013, repriced
 
2,907,347
 
$
0.27
 
3.21
 
Stock purchase warrants issued
 
17,991,000
 
 
0.19
 
5.0
 
Stock purchase warrants exercised
 
—
 
 
—
 
 
 
Shares purchasable under outstanding warrants at March 31, 2014
 
20,898,347
 
$
0.20
 
3.21 - 5.0
 
 
Warrant activity during the nine months ended March 31, 2013, and related balances outstanding as of such dates are reflected below:
 
 
 
Number
 
Weighted
Average
Exercise
Price Per
Share
 
Remaining
Contract
Term (#
years)
 
Shares purchasable under outstanding warrants at June 30, 2012
 
2,400,328
 
$
0.41
 
 
 
Stock purchase warrants issued
 
507,019
 
 
0.41
 
 
 
Stock purchase warrants exercised
 
—
 
 
—
 
 
 
Shares purchasable under outstanding warrants at March 31, 2013
 
2,907,347
 
$
0.41
 
4.59 – 4.21
 
Stock Options Activity
Activity in stock options during the nine months ended March 31, 2014, and related balances outstanding as of that date are reflected below:
 
 
 
Number of
Shares
 
Weighted
Average
Exercise Price
Per Share
 
Weighted
Average
Remaining
Contract
Term (# years)
 
Outstanding at June 30, 2013
 
 
2,527,389
 
$
0.15
 
 
5.85
 
Granted
 
 
5,310,973
 
 
 
 
 
 
 
Exercised
 
 
—
 
 
 
 
 
 
 
Forfeited and cancelled
 
 
(792,836)
 
 
 
 
 
 
 
Outstanding at March 31, 2014
 
 
7,045,526
 
$
0.18
 
 
8.57
 
Exercisable at March 31, 2014
 
 
3,317,097
 
$
0.14
 
 
8.02
 
 
Activity in stock options during the nine months ended March 31, 2013, and related balances outstanding as of that date are reflected below:
 
 
 
Number of
Shares
 
Weighted
Average
Exercise Price
Per Share
 
Weighted
Average
Remaining
Contract
Term (# years)
 
Outstanding at June 30, 2012
 
 
4,536,949
 
$
0.17
 
 
7.61
 
Granted
 
 
—
 
 
 
 
 
 
 
Exercised
 
 
(549,552)
 
 
 
 
 
 
 
Forfeited and cancelled
 
 
(1,430,050)
 
 
 
 
 
 
 
Outstanding at March 31, 2013
 
 
2,557,347
 
$
0.15
 
 
7.19
 
Exercisable at March 31, 2013
 
 
1,843,217
 
$
0.21
 
 
6.56
 
Employee Option Grants and Non-employee Option Grants
We allocated stock-based compensation expense included in the condensed consolidated statements of operations for employee option grants and non-employee option grants as follows:
 
 
 
For the Three Months Ended
 
For the Nine Months Ended
 
 
 
March 31, 
2014
 
March 31, 
2013
 
March 31, 
2014
 
March 31, 
2013
 
Research and development
 
$
4,000
 
$
3,000
 
$
7,000
 
$
10,000
 
General and administration
 
 
129,000
 
 
26,000
 
 
186,000
 
 
57,000
 
Total stock-based compensation expense
 
$
133,000
 
$
29,000
 
$
193,000
 
$
67,000
 
Stock Options Valuation Assumptions
The Company uses the Black-Scholes valuation model to calculate the fair value of stock options. The fair value of stock options was measured at the grant date using the assumptions (annualized percentages) in the table below:
 
Nine months ended March 31,
 
2014
 
2013
 
Expected volatility
 
218%
 
100%
 
Risk free interest rate
 
0.7% to 1.7%
 
0.8% to 3.0%
 
Forfeiture rate
 
13%
 
5%
 
Dividend yield
 
0%
 
0%
 
Expected term
 
3-5 years
 
5-10 years